The United States Food and Drug Administration (US FDA) has placed Sun Pharmaceuticals' Halol unit under 'import alert'. This implies that all future shipments of products manufactured at this facility are subject to refusal of admission to the US market until the facility becomes compliant with cGMP standards.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/jW3rpu5
via IFTTT
0 comments:
Post a Comment